The first four cases against hip implant manufacturer Stryker Corp. for its recalled Rejuvenate and ABG II implants have settled and more settlements are expected.
Attorneys for the four patients settled the lawsuits for an undisclosed amount in New Jersey state court. Those close to the cases believe the settlements are just the first wave of expected settlements in the coming months.
The Stryker settlements come on the heels of the record-setting $2.5 billion settlement by DePuy Orthopaedics of 8000 similar lawsuits. About 4000 Depuy cases are still outstanding and Stryker is facing at least 1000 cases in federal and state courts.
Hip Implants Giving Patients and Stryker Problems
Before they were recalled in 2012, a little over 20,000 patients received Stryker’s Rejuvenate or ABG II hip implants. The devices, which consist of a metal neck and metal stem, were created to be a longer lasting alternative to plastic or ceramic implants. Instead, devices began failing and causing injuries to patients just months after being implanted.
In July 2012, Stryker recalled the devices saying “fretting and corrosion at the modular neck junction,” were responsible for the recall.
The metal neck and metal stem grind against each other causing the implants to shed metallic particles into the surrounding tissue and bloodstream. Patients who received the faulty devices claim to have suffered side effects including:
- Allergic reactions
- Bone loss
- Necrosis (bone and tissue death)
- and Metallosis (metal poisoning)
Stryker hip complications often require painful revision surgeries to remove the failed device and replace it with a new implant. The pain and recovery period is often longer and more difficult than that of the original surgery.
FREE Stryker Implant Case Review
If you or a loved received a Stryker Rejuvenate or an ABG II hip replacement, you could be owed substantial compensation.
Lawsuits Hurt Stryker’s Bottom Line
While the settlements are confidential barring attorneys from discussing how much money patients received, there is clear evidence that the on-going lawsuits are affecting Stryker’s bottom line.
The companies third quarter net earnings fell 70 percent from the same quarter last year and issues related to the recall of Rejuvenate and ABG II cost the company more than $700 million so far.
While Stryker and Depuy have received the largest share of the press about metal-on-metal hip implants they are not the only manufacturers involved in lawsuits. Biomet, an Indiana based company is facing more than 900 cases in federal court. Smith & Nephew and Wright Medical also face lawsuits involving their hip implants.